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1. Introduction composition of released fragments was analysed with 
the aim of elucidating the biological functions of C4. 
The fourth component of human ,complement is a 
glycoprotein of Mr - 190 000 [l-3]. C4 consists of 
three polypeptide chains (a&,~) linked together by 
non-covalent forces and disulfide bridges [4]. 
2. Materials and methods 
When activated by Cis, C4 is cleaved, releasing a 
small peptide, C4a, of M, - 10 000 [5,6].This peptide 
is spasmogenic for guinea pig ileum and tachyphy- 
lactic for human C3a anaphylatoxin [7]. The rest of 
the molecule after Cis cleavage, i.e., C4b, can bind to 
the cell surface via a labile binding site. C4b, on the 
cell surface or in solution, is easily cleaved by the C4b 
inactivator (C4bINA) [8] in the presence of CCbind- 
ing protein (C4bp) [9,10]. Two fragments are pro- 
duced, namely C4d, a fragment of the a-chain, and 
C4c, which consists of the residual a-chain and the 
intact /?- and y-chains. 
Fresh frozen ACD-plasma from healthy adult, pur- 
chased from the University Hospital (Uppsala) served 
as the origin for preparation of complement compo- 
nents. Sheep erythrocytes and rabbit antisheep hemo- 
lysin were from the National Bacteriological Lab. 
(Stockholm). D,L-Dithiothreitol (DTT) was pur- 
chased from Sigma (St Louis MO). L-(Tosylamide-2- 
phenyl-ethyl-chloromethyl-ketone)-treated trypsin 
with spec. act. 224 units/mg and soybean trypsin 
inhibitor (SBTI) were purchased from Worthington 
Biochemical Corp. (Freehold NJ). 
2.1. Human complement components 
One of the biological functions of C4 in the com- 
plement cascade is to form a complex with C2. This 
complex, stabilized by Cis [ 111, generates proteo- 
lytic activity against C3, which is split and activated. 
We have shown that methylamine-treated C4 is 
hemolytically inactive but combines with C2 to elicit 
convertase activity against C3. Here trypsin was used 
for degradation of highly purified human C4. The 
Highly purified C2 and C4 and partially purified 
CT were isolated as in [ 121, [3] and [ 13,141, respec- 
tively. Treatment of C4 with [ “C]methylamine at 
slightly alkaline pH was performed as in [ 151. [r4C]- 
Methylamine is incorporated into the o-chain of C4 at 
a ratio of 1 mol methylamine/mol C4. Here, [14C]- 
methylamine was used as a marker of the a-chain to 
follow the breakdown by autoradiography. 
Abbreviations: DTT, dithiothreitol; SBTI, soybean trypsin 
inhibitor; EDTA, ethylene diamine tetraacetic acid; SDS, 
sodium dodecyl sulphate; PBS, phosphate-buffered saline 
(pH 7.4); GVB, Verona1 buffer containing 0.1% gelatin; 
GVBE, gelatin Verona1 (barbitone) buffer containing 0.04 M 
EDTA; M,, relative molecular mass 
2.2. Hemolytic titration of complement components 
Effective molecules (EM) of C2 [ 161 and C4 [ 131 
were determined according to established methods. 
2.3. Immunoelectrophoresis 
Nomenclature: Complement components follow the recom- 
mendations by the World Health Organization (1968). A bar 
above the complement component (e.g., cis) Signifies an 
enzymatically active form 
Experiments were carried out on glass plates con- 
taining 1% agarose dissolved in 0.01 M Tris-HAc 
buffer (pH 8.6) containing 0.002 M EDTA for 2 h 
at 50 V. 
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2.4. Antisera 2.7. Formation of a C44C2 complex 
Monospecific rabbit antisera against human C4 
were purchased from Behringwerke AG (Marburg). 
Antisera against C4, trypsinized for 1.5 h at 37’C 
with a substrate:enzyme ratio of 50: 1, were raised in 
rabbits. The antiserum against trypsinized C4 also con- 
tains antibodies against the trypsin/SBTI complex. 
2.5. Polyacrylamide gel electrophoresis 
Sodium dodecyl sulphate (SDS) gel electrophoresis 
was carried out on 11% slab gels, using a discontinu- 
ous buffer system [ 171. Sample proteins (20 pg), 
diluted in an equal volume of 8 M urea, containing 
2% SDS with or without 50 mM DTT, were incubated 
at 37°C for 60 min before being loaded on the gel. 
A drop of tracking dye, 0.1% bromophenol blue, in 
water, was added and electrophoresis was carried 
out at room temperature for 4 h. at 200 mA. The gel 
was stained with 0.25% Coomassie brilliant blue for 
16 h and destained in methanol:acetic acid:water 
(25:7.5:67.5). 
Trypsinized C4 (16 pg) in 200 ~1 GVB were incu- 
bated with an equal volume of oxidized C2 (1 X lo9 
EM/ml) for I5 min at 37°C. After incubation, remain- 
ing 0xYC2 hemolytic activity was assayed by adding 
2.4 ml guinea pig serum diluted 1: 100 in GVBE. Bind- 
ing of trypsinized C4 to OxYC2 lowers the 0xYC2 
hemolytic activity and is expressed in the following 
as percent inhibition of 0xYC2-dependent hemolysis. 
Native C4 was incubated with 0xYC2 as a positive 
control for total inhibition of OxYC2 hemolytic activ- 
ity; as a negative control OxYC2 was incubated with 
buffer. The effect of trypsin, SBTI and trypsin/SBTI 
complex on OxYC2 hemolytic activity was also tested. 
3. Results 
The cleavage of C4 by trypsin as a function of 
time was analyzed by immunoelectrophoresis, by 
polyacrylamide gel electrophoresis, by the ability to 
interact with C2, and by C4 hemolytic titrations. 
Slab gel with reference proteins of known M, was 
run in the same way. The negative logarithms of the 
relative mobilities of these proteins were plotted 
against Mr. The curve obtained was used for calculat- 
ing the Mr values of fragments of C4. After staining, 
the gel was cut to give parallel strips about 10 mM 
wide and these strips were analyzed in a Gilford spec- 
trophotomet&, model 2541, at 541 nm. Autoradiog- 
raphy was carried out by exposing the stained and 
dried slab gel to an X-ray film (Kodak X-Omat RS) 
at room temperature for l-2 weeks. 
3 .l . Immunoelectrophoretic analyses 
Proteolysis of C4 was accompanied by changes in 
its immunoelectrophoretic pattern as illustrated by 
the use of monospecific rabbit antihuman C4 serum 
(fig.lA). After 1 min incubation with trypsin, a faster 
mobility of C4 towards the anode is seen. The mate- 
rial might have further increased its anodicity after 
degradation for 2 h. 
2.6. Cleavage of C4 by trypsin 
Highly purified C4 at 0.8 mg/ml and with 7.0 X IO” 
effective molecules/ml was incubated at 37°C with 
trypsin (2.5 mg/ml in PBS) at a substrate:enzyme 
ratio of 50: 1 (w/w). At known time intervals 150 ~1 
of the mixture were withdrawn and the trypsin activ- 
ity was neutralized by adding a 4-fold weight excess 
of SBTI (5 mg SBTI/ml PBS) over trypsin. Reaction 
mixture (25 ~1) was subjected to SDS-polyacryl- 
amide gel electrophoresis and 10 ~1 samples were ana- 
lyzed by immunoelectrophoresis; 16 ~1 were diluted 
with GVB to 200 ~1 and used for testing the inter- 
action with C2. C4 hemolytic activity was tested on 
samples serially diluted from 1: 500 in a total volume 
of 0.4 ml. 
The troughs in fig.1 B contain antiserum against C4 
degradation products produced as in section 2. C4 
trypsinized for 1 min shows a faster /?-mobility arc 
than intact C4, and 5 min trypsin treatment gives rise 
to a new arc of a-mobility. This arc increases up to 
20-30 min of trypsin digestion and then remains 
unchanged up to 120 min of this treatment. 
3.2. SDS-polyacrylamide gel analyses 
C4 migrated on SDS-polyacrylamide slab gel as 
a single protein band of Mr 189 000. In the presence 
of a reducing agent, C4 was split into 3 chains: 
a-chain (M, 88 000), P-chain (M, 72 000) and y-chain 
(M, 32 000). Incubation of C4 with trypsin resulted 
in progressive degradation of C4. As illustrated in 
fig.2, incubation of C4 for 1 min at 37°C with 2% 
(w/w) trypsin resulted primarily in cleavage of the 
a-chain into a residual &‘-chain of reduced molecular 
size (M, 81 500). Prolonged degradation affects the 
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Fig.1. Immunoelectrophoretic analysis of the cleavage of human C4 by trypsin. C4 (0.8 mg/ml) was digested with trypsin at a 
substrate:enzyme ratio of 5O:l. The reaction was terminated by adding SBTI at known time intervals and 10 nl of the mixtures 
was analyzed. The troughs in (A) contain monospecific rabbit anti-human C4 and in (B) rabbit antiserum against C4 digested with 
trypsin for 1.5 h. 
CY’-, /3- and y-chains. After -1 O-20 min these are com- 
pletely fragmented. The principal fragments formed 
during a digestion period of up to 2 h, which are 
stainable with Coomassie brilliant blue, have M,-values 
of 60 500,28 000,24 000,20 000 and <lo 000. 
To further estimate the breakdown pattern, [r4C]- 
methylamine-treated C4 was trypsinized. Methyl- 
amine is incorporated into the a-chain of C4 and the 
degradation of [ “C]methylamine-labelled o-chain of 
C4 was recorded by autoradiography of the stained 
and dried slab gel (fig.3). During the digestion period 
the 14C-label of the o-chain is progressively found in 
fragments with Mr of 81 500,60 500,41 000 and
28 000 (fig.3). At least the last fragment showed 
0’ 1’ 2’ 3’ 4’ 6’ 10’ 15’20’ 30’ 60’ 120’ 
- - - 60500 
k 
---41000 _-- 
-- - 28000 
Fig.2. SDS-Polyacrylamide slab gel electrophoresis of C4, treated with trypsin at 37°C in a substrate:enzyme ratio of 50: 1. 
Digestion was terminated at known intervals of time by a 4-fold molar excess of SBTI over trypsin. Samples were reduced with 
25 mM DTT in 4 M urea and 1% SDS for 1 h at 37°C before being loaded on the 11% polyacrylamide slab gel. 
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Fig.3. Autoradiography of [ 14C] methylaminated and trypsinized C4:The material was digested at 37°C with 2% trypsin, and 
after reduction with 25 mM DTT in 4 M urea and 1% SDS was subjected to electrophoresis on a polyacryhmide slab gel. After 
staining and drving. the gel was exposed to an X-ray film at room temperature for 2 weeks. Indicated on the left side of the devel- 
aped X-ray film is part of the stained gel at zero time of digestion. 
microheterogeneity. These fragments correspond to 
fragments found in the gel stained by Coomassie bril- 
liant blue. 
The fragments on polyacrylamide slab gel pro- 
duced after 2 h digestion were tested by immunodif- 
fusion against anti&chain and anti-y-chain serum. 
The fragment with M, of 60 500 precipitated the 
anti-&chain serum. No precipitation was obtained by 
the anti-y-chain serum. 
3.3. Biological activities of degraded C4 
The ability of C4 and its degradation products to 
convert EACl to hemolytically active EAC14 inter- 
mediates was examined. For this purpose degraded C4 
was added to EACI cells, the cells were washed and 
OxYC2 and guinea pig EDTA-serum was added. Tryp- 
sin treatm‘ent of C4 for 1 min reduced the hemolytic 
activity of this system to <l% of that of native C4. 
The interaction between C4 and C2 in solution 
was studied by incubating C4 or its degradation prod- 
ucts with C2 and subsequently measuring the remain- 
ing C2 hemolytic activity. The inhibitory activity of 
C4, degraded at 37°C for different periods of time, is 
illustrated in fig.4. Undegraded C4 showed even lower 
inhibitory activity than C4 digested for 1-3 min. The 
interaction with material digested for 5- 10 min 
rapidly declines. 
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To further investigate the breakdown products, 
stained gel strips were scanned in a Gilford spectro- 
photometer model 2541. The cleavage of the P-chain 
seemed to correlate fairly well with the loss of 
C2-complexing activity of C4. Trypsin treatment for 
5 min left -56% of the P-chain. 
t 
fMIN 1 2 345 10 30 
'IME 
Fig.4. The ability of C4, trypsinized for a given time, to form 
a complex with 0xyC2 expressed as inhibition of 0xyC2 , 
hemolytic activity. 
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4. Discussion 
Earlier reports on the degradation of C4 have 
mostly concerned the natural enzymes Cis, which 
splits C4 into C4a and C4b, and C4bINA, which splits 
the molecule into C4c and C4d. Treatment of C4 
with 1% trypsin (w/w) for 1 min at 20°C totally 
abrogated the C4 hemolytic activity in [6]. This find- 
ing was confirmed in our study. The first tryptic 
attack is directed at the o-polypeptide chain, as is also 
evident from the polyacrylamide gel at a site respon- 
sible for binding of C4 onto the cell surface. More- 
over, the mobility of trypsinized C4 on immunoelec- 
trophoresis has been reported [6] to be slower than 
that of intact C4, an observation which is not in 
accordance with our result that trypsin-treated C4 had 
a faster P-mobility. A cathodal shift of the /3-mobility 
arc has been observed, however, after cleavage of C4b 
by C4bINA [ 181 together with the generation of a 
new arc of a-mobility. The o-mobility arc appeared 
here (fig.lB) after 5 min trypsin treatment and per- 
sisted for up to 120 min degradation when an anti- 
serum against C4 degradation products was used. 
The cleavage of C4b by trypsin differs at least 
partly from the reported cleavage by C4bINA and 
C4bp, which are directed only against the cr’-polypep- 
tide chain. Trypsin also cleaves both the /3- and 
y-chains. Cleavage of the p-chain by crude prepara- 
tions of C4bIBA, released a fragment from the P-chain 
of Mr < 20 000 [8]. This attack can be accounted for 
by proteases, e.g., trypsin or plasmin, as it is quite in 
accordance with our results obtained in a purified 
system of C4 and trypsin. The remaining product of 
the p-chain has a calculated Mr of 61 500. 
The cleavage of C4bINA and C4bp has been stated 
to give rise to 2 [8] or 3 [9] fragments from the 
o-chain of C4b with different Mr-values. In [lo] the 
&‘-chain was found to be first split by C4bINA and 
C4bp to a small fragment of Mr 16 000 and a large 
fragment the J4, of which (73 000) was very close to 
that of the B-chain. Secondary cleavage of the large 
fragment yielded an M, 45 000 fragment (C4d), and 
an M, 27 000 fragment of the al-chain which together 
with intact f3- and y-chains constitutes C4c in addition 
to the M, 16 000 fragment. These data are partly in 
agreement with ours. The initial attack by trypsin was 
directed at the a-polypeptide chain, resulting in an 
o-chain which rendered the molecule hemolytically 
inactive but still able to form a complex with C2. Fur- 
ther trypsin treatment gave an off-chain (M, 60 500), 
as evaluated by autoradiography of [“C]methyl- 
aminated C4. A very low concentration of trypsin 
released an intermediate fragment of the a-chain of 
M* - 66 000. Cleavage of the P-chain occurred only 
when the a-chain was almost totally degraded. This 
parallelled the lost ability of C4 to complex with C2, 
as shown by scanning of the stained gel strips. 
Degradation for 2 h gave a radiolabelled fragment 
of M, 28 000, a fragment not linked by disulphide 
bridges to the /3- and y-chains [ 151. This fragment elic- 
ited by trypsin resists further degradation by proteo- 
lytic enzymes, is micro-heterogeneous, has an cr-mobil- 
ity on immunoelectrophoresis and contains a thiol 
ester [20]. Similar data have been reported for C4d 
[9], and probably the C4d fragment of M, 45 000 is 
rapidly split by trypsin to a lower M, of 28 000. 
Trypsin cleavage of human C4 has been described 
in [21]. The breakdown pattern as evaluated by poly- 
acrylamide gel electrophoresis [21] is in accordance 
with that observed here in that the a-chain was readily 
cleaved (at room temperature), while the P-chain was 
not totally degraded after 1 h. The calculated M, of 
fl’, the main breakdown product of the P-chain, was 
66 000 and compares to our value of 60 500. In [21] 
the y-chain was reported to remain intact after 60 min 
trypsin treatment, which is contrary to our result. A 
possible explanation for the discrepancy is that the 
band seen after 60 min of degradation is not an intact 
y-chain but an o-chain fragment of M, 28 000, i.e., 
very close to the M, of the y-chain. 
Native C4 and C2 tend to interact in free solution 
to form a reversible protein-protein complex [ 1 l] 
which is converted into a stable complex by the 
action of Cl esterase. These molecular complexes 
between C4 and C2 are precursors of an enzyme 
which is generated through the action of Cl esterase. 
Our studies were undertaken to determine whether 
C4, when partly broken down by trypsin, was still 
able to form a complex with C2. We found that 
neither an intact a+ nor an intact al-chain was a pre- 
requisite for complex formation with C2 but that a 
non-digested P-chain was required. As soon as the 
P-chain starts to proteolyse, the complex formation 
between C4 and C2 decreases. It is an open question 
[ 101 whether a nicked form of C4b (C4b’) is able to 
bind C2. It is quite obvious, however, that the tryptic 
fragment of M, 28 000 is not responsible for the 
binding of C2. This fragment is present after 2 h tryp- 
sinization, when no C2 binding takes place. The fact 
that a partly degraded C4 is still able to form a com- 
191 
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plex with C2 and is perhaps able to generate C3 con- 
vertase may be of physiological importance. We have 
shown that methyiamine-treated C4, although hemo- 
lytically inactive, can form a fluid phase convertase 
with C2 and Cl, and most probably the same is true 
for partially degraded C4. 
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